Skip to content

Insider · CIK 0001808098

Johnson David Michael

Reports to the SEC for 2 companies · SAN DIEGO, CA

Transactions

50

Companies

2

Filings

10

CIK

0001808098

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-06-16ZNTLZentalis Pharmaceuticals, Inc.A Award—
2026-06-11AURAAura Biosciences, Inc.A Award—
2026-06-11AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2025-06-17AURAAura Biosciences, Inc.A Award—
2025-06-17AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2025-06-17ZNTLZentalis Pharmaceuticals, Inc.A Award—
2025-05-16AURAAura Biosciences, Inc.P Purchase+$98K
2025-05-16AURAAura Biosciences, Inc. · Common Stock Warrants (right to buy)P Purchase—
2024-06-21ZNTLZentalis Pharmaceuticals, Inc.A Award—
2024-06-20AURAAura Biosciences, Inc.A Award—
2024-06-20AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2023-11-10ZNTLZentalis Pharmaceuticals, Inc.P Purchase+$168K
2023-11-08AURAAura Biosciences, Inc.P Purchase+$70.1K
2023-11-08AURAAura Biosciences, Inc.P Purchase+$73K
2023-11-08AURAAura Biosciences, Inc.P Purchase+$73K
2023-11-07AURAAura Biosciences, Inc.P Purchase+$545K
2023-11-07AURAAura Biosciences, Inc.P Purchase+$337K
2023-11-07AURAAura Biosciences, Inc.P Purchase+$337K
2023-10-04AURAAura Biosciences, Inc.P Purchase+$56.5K
2023-10-03AURAAura Biosciences, Inc.P Purchase+$112K
2023-06-16ZNTLZentalis Pharmaceuticals, Inc.A Award—
2023-06-07AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2023-01-06AURAAura Biosciences, Inc.P Purchase+$7,350
2023-01-06AURAAura Biosciences, Inc.P Purchase+$9,501.04
2023-01-05AURAAura Biosciences, Inc.P Purchase+$3,000
2023-01-05AURAAura Biosciences, Inc.P Purchase+$960
2022-12-28AURAAura Biosciences, Inc.P Purchase+$19.5K
2022-12-28AURAAura Biosciences, Inc.P Purchase+$19.5K
2022-12-01AURAAura Biosciences, Inc.P Purchase+$61.8K
2022-12-01AURAAura Biosciences, Inc.P Purchase+$61.8K
2022-06-15AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2022-06-13AURAAura Biosciences, Inc.P Purchase+$97.9K
2022-06-13AURAAura Biosciences, Inc.P Purchase+$97.9K
2022-06-13AURAAura Biosciences, Inc.P Purchase+$280K
2022-06-10AURAAura Biosciences, Inc.P Purchase+$45.1K
2022-06-10AURAAura Biosciences, Inc.P Purchase+$45.1K
2022-06-10AURAAura Biosciences, Inc.P Purchase+$150K
2022-06-08ZNTLZentalis Pharmaceuticals, Inc.A Award—
2021-11-02AURAAura Biosciences, Inc.C Conversion—
2021-11-02AURAAura Biosciences, Inc. · Series E Convertible Preferred StockC Conversion—
2021-10-28AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award—
2021-10-04ZNTLZentalis Pharmaceuticals, Inc.S Sale−$323K
2021-10-04ZNTLZentalis Pharmaceuticals, Inc.S Sale−$526K
2021-10-04ZNTLZentalis Pharmaceuticals, Inc.S Sale−$6,720
2021-06-04ZNTLZentalis Pharmaceuticals, Inc.A Award—
2021-06-04ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2021-06-04ZNTLZentalis Pharmaceuticals, Inc.A Award—
2021-06-04ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2021-04-05ZNTLZentalis Pharmaceuticals, Inc.S Sale−$561K
2020-12-02ZNTLZentalis Pharmaceuticals, Inc.S Sale−$79.7K

Recent filings

10

Companies

2

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121